Clopidogrel Terminated Phase 3 Trials for Acute Coronary Syndromes (ACS) / Atherosclerosis Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00385138Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.